2014-77-9

Usage

Synthesis Reference(s)

The Journal of Organic Chemistry, 28, p. 2589, 1963 DOI: 10.1021/jo01045a025

InChI:InChI=1/C9H13NS/c1-8(10)7-11-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3

Upstream product

• 91281-29-7 N-[1-methyl-2-(phenylthio)ethyl]acetamide 
• 27872-74-8 phenylmercaptopropanone oxime 
• 108-98-5 thiophenol 
• 75-55-8 2-Methylaziridine 
• 5042-53-5 1-(phenylsulfanyl)acetone 

Downstream Products

• 116143-17-0 7-Chloro-6-fluoro-1-(1-methyl-2-phenylsulfanyl-ethyl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 22039-88-9 1-Phenylthio-2-propyl-isocyanat 
• 958261-88-6 N-[(10-bromo-2,3,6-trimethoxyphenanthren-9-yl)methyl]-N-[1-methyl-2-(phenylsulfanyl)ethyl]amine 
• 958261-94-4 N-[1-methyl-2-(phenylsulfanyl)ethyl]-[9-bromo-2,3,6-trimethoxyphenanthren-10-yl]methylamine 
• 116143-18-1 6-Fluoro-7-chloro-1-(2-(phenylsulfinyl)-1-methylethyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 
• 116143-19-2 7-Piperazinyl-6-fluoro-1-(2-(phenylsulfinyl)-1-methylethyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

Sulfur, selenium and tellurium containing amines act as effective carbonic anhydrase activators

A new series of β-aminochalcogenides were designed and synthesized to identify new carbonic anhydrase activator (CAA) agents as novel tools for the management of several neurodegenerative and metabolic disorders which represent a clinical challenge withou

A sulfur-containing amino acid amide carbamate derivative and application thereof

The invention belongs to the field of plant fungicides, and relates to sulfur-containing amino acid amide carbamate derivatives of which the general formulas I are shown in the description and pharmaceutically acceptable salts of the sulfur-containing amino acid amide carbamate derivatives. In the general formulas I, substituent groups R1, R2 and n are defined in the description. The invention further relates to preparation methods of compounds related to the general formulas I, special intermediates developed for the preparation of the compounds, and application of the compounds to prevention and control of plant diseases.

Synthesis of mexiletine analogues from non-activated aziridines

A general method for the synthesis of mexiletine analogues by nucleophilic ring opening of non-activated racemic aziridines has been developed (Scheme 1). Structural variation is introduced by employing different nucleophiles or by altering the substitution on the aziridine ring.